Back to Screener

Healthcare

WOWI, Inc.(WOWU)

Live Price

Offline

$0.0002

+0.00% today

1Y Change

+0.00%

Window

Jun 23, 2025 โ†’ Jun 16, 2026

Market Cap
โ€”
Revenue Growth
-33.6%
EPS Growth
-68.6%
Dividend Yield
0.0%

Coverage: 247 bars ยท Jun 23, 2025 โ†’ Jun 16, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

WOWI, Inc. (WOWU) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 โ†’ Jun 16, 2026). Baseline metrics include revenue growth of -33.6%, EPS growth of -68.6%, a dividend yield of 0.0%. What stands out right now is revenue -33.6%, EPS -68.6%, free cash flow 0.0% with operating margin 23.5% and ROIC 233.4%. Valuation is more restrained than many high-expectation growth names at P/E 0.1 and price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines WOWU price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

WOWU

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

WOWU Max Drawdown

0.00%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for WOWU and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

WOWI, Inc. (WOWU)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$0.0

-100.0% YoY

FY Net Income

-$34.4M

-15737.6% YoY

Free Cash Flow

-$77.8K

-70543.2% YoY

Revenue Growth

-33.6%

EPS Growth

-68.6%

Gross Margin

91.8%

Net Margin

23.5%

Income statement

USD

Annual
Metric20232022202120202017
Revenue390K588K323K85K0
Gross Profit358K556K323K85K-6K
Operating Income92K289K-24K-217K-31M
EBITDA124K321K-11K-204K-34M
Net Income92K289K-24K-217K-34M
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

USD

Point-in-time
Metric20232022202120202017
Cash & Equivalents0000178K
Total Assets2M2M1M1M830K
Total Liabilities2M2M1M1M212K
Shareholder Equity-41K157K-132K-108K618K
Total Debt80K80K80K80K10K
Net Debt80K80K80K80K-168K

Cash flow positioning

Latest Full Year

Operating Cash Flow

68K

-62078.1% YoY

Capital Expenditures

9K

Free Cash Flow

78K

-70543.2% YoY

Key ratios

  • Gross Margin

    91.8%

  • Operating Margin

    23.5%

  • Net Margin

    23.5%

  • ROE

    158.0%

  • Debt / Equity

    -1.97x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.